Cassia Overk

Title(s)Project Scientist, Neurosciences
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Potential sedative mechanism for Humulus lupulus L.
    NIH F31AT002423Aug 1, 2004 - Jul 31, 2007
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Nicotine-mediated effects in neuronal and mouse models of synucleinopathy. Front Neurosci. 2023; 17:1239009. Fares MB, Alijevic O, Johne S, Overk C, Hashimoto M, Kondylis A, Adame A, Dulize R, Peric D, Nury C, Battey J, Guedj E, Sierro N, Mc Hugh D, Rockenstein E, Kim C, Rissman RA, Hoeng J, Peitsch MC, Masliah E, Mathis C. PMID: 37719154; PMCID: PMC10501483.
      View in: PubMed   Mentions:
    2. Modeling Alzheimer's disease related phenotypes in the Ts65Dn mouse: impact of age on Aβ, Tau, pTau, NfL, and behavior. Front Neurosci. 2023; 17:1202208. Overk C, Fiorini E, Babolin C, Vukicevic M, Morici C, Madani R, Eligert V, Kosco-Vilbois M, Roberts A, Becker A, Pfeifer A, Mobley WC. PMID: 37449271; PMCID: PMC10336548.
      View in: PubMed   Mentions:
    3. Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD. Sci Transl Med. 2023 05 10; 15(695):eabq6089. Iba M, Kim C, Kwon S, Szabo M, Horan-Portelance L, Peer CJ, Figg WD, Reed X, Ding J, Lee SJ, Rissman RA, Cookson MR, Overk C, Wrasidlo W, Masliah E. PMID: 37163617.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    4. Novel Brain-Penetrating Single Chain Antibodies Directed Against 3RTau for the Treatment of Alzheimer's Disease and Related Dementias. Methods Mol Biol. 2022; 2383:447-457. Spencer B, Rissman RA, Overk C, Masliah E. PMID: 34766306.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model. Alzheimers Dement. 2022 06; 18(6):1203-1234. Sawa M, Overk C, Becker A, Derse D, Albay R, Weldy K, Salehi A, Beach TG, Doran E, Head E, Yu YE, Mobley WC. PMID: 34757693; PMCID: PMC9085977.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    6. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model. Alzheimers Dement. 2021 02; 17(2):271-292. Chen XQ, Salehi A, Pearn ML, Overk C, Nguyen PD, Kleschevnikov AM, Maccecchini M, Mobley WC. PMID: 32975365; PMCID: PMC7984396.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    7. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models. J Neuroinflammation. 2020 Jul 17; 17(1):214. Iba M, Kim C, Sallin M, Kwon S, Verma A, Overk C, Rissman RA, Sen R, Sen JM, Masliah E. PMID: 32680537; PMCID: PMC7368752.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    8. Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like model. Alzheimers Dement. 2019 09; 15(9):1133-1148. Mandler M, Rockenstein E, Overk C, Mante M, Florio J, Adame A, Kim C, Santic R, Schneeberger A, Mattner F, Schmidhuber S, Galabova G, Spencer B, Masliah E, Rissman RA. PMID: 31378574; PMCID: PMC7503212.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    9. Could changing the course of Alzheimer's disease pathology with immunotherapy prevent dementia? Brain. 2019 07 01; 142(7):1853-1855. Overk C, Masliah E. PMID: 31505546; PMCID: PMC6933504.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    10. Pathogenesis of age-related HIV neurodegeneration. J Neurovirol. 2019 10; 25(5):622-633. Mackiewicz MM, Overk C, Achim CL, Masliah E. PMID: 30790184; PMCID: PMC6703984.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    11. Remembering Robert D. Terry at a Time of Change in the World of Alzheimer's Disease. J Alzheimers Dis. 2019; 70(3):621-628. Terry N, Masliah A, Overk C, Masliah E. PMID: 31282421; PMCID: PMC6750985.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Effects of Novel Calpain Inhibitors in Transgenic Animal Model of Parkinson's disease/dementia with Lewy bodies. Sci Rep. 2018 12 27; 8(1):18083. Hassen GW, Kesner L, Stracher A, Shulman A, Rockenstein E, Mante M, Adame A, Overk C, Rissman RA, Masliah E. PMID: 30591714; PMCID: PMC6308237.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    13. Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau. J Alzheimers Dis. 2018; 61(3):1201-1219. Arner A, Rockenstein E, Mante M, Florio J, Masliah D, Salehi B, Adame A, Overk C, Masliah E, Rissman RA. PMID: 29332037; PMCID: PMC6508863.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    14. Dale Schenk One Year Anniversary: Fighting to Preserve the Memories. J Alzheimers Dis. 2018; 62(1):1-13. Overk C, Masliah E. PMID: 29439357.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies. J Neurosci. 2018 01 24; 38(4):1000-1014. Rockenstein E, Ostroff G, Dikengil F, Rus F, Mante M, Florio J, Adame A, Trinh I, Kim C, Overk C, Masliah E, Rissman RA. PMID: 29246926; PMCID: PMC5783958.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    16. Multiple system atrophy: experimental models and reality. Acta Neuropathol. 2018 01; 135(1):33-47. Overk C, Rockenstein E, Valera E, Stefanova N, Wenning G, Masliah E. PMID: 29058121; PMCID: PMC6156777.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    17. Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy. Neurobiol Dis. 2017 Aug; 104:85-96. El-Agnaf O, Overk C, Rockenstein E, Mante M, Florio J, Adame A, Vaikath N, Majbour N, Lee SJ, Kim C, Masliah E, Rissman RA. PMID: 28476636; PMCID: PMC5954414.
      View in: PubMed   Mentions: 41     Fields:    Translation:AnimalsCells
    18. Perspective on the calcium dyshomeostasis hypothesis in the pathogenesis of selective neuronal degeneration in animal models of Alzheimer's disease. Alzheimers Dement. 2017 02; 13(2):183-185. Overk C, Masliah E. PMID: 28130011; PMCID: PMC5935121.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    19. The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. J Neurovirol. 2017 04; 23(2):290-303. Fields JA, Metcalf J, Overk C, Adame A, Spencer B, Wrasidlo W, Florio J, Rockenstein E, He JJ, Masliah E. PMID: 28105557; PMCID: PMC5729903.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    20. Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy. Acta Neuropathol Commun. 2017 01 13; 5(1):7. Spencer B, Valera E, Rockenstein E, Overk C, Mante M, Adame A, Zago W, Seubert P, Barbour R, Schenk D, Games D, Rissman RA, Masliah E. PMID: 28086964; PMCID: PMC5237270.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    21. A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease. Brain. 2016 12; 139(Pt 12):3217-3236. Wrasidlo W, Tsigelny IF, Price DL, Dutta G, Rockenstein E, Schwarz TC, Ledolter K, Bonhaus D, Paulino A, Eleuteri S, Skjevik ÅA, Kouznetsova VL, Spencer B, Desplats P, Gonzalez-Ruelas T, Trejo-Morales M, Overk CR, Winter S, Zhu C, Chesselet MF, Meier D, Moessler H, Konrat R, Masliah E. PMID: 27679481; PMCID: PMC5840882.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansAnimals
    22. Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model. J Neurosci. 2016 07 27; 36(30):7971-84. Spencer B, Desplats PA, Overk CR, Valera-Martin E, Rissman RA, Wu C, Mante M, Adame A, Florio J, Rockenstein E, Masliah E. PMID: 27466341; PMCID: PMC4961781.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    23. Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies. Sci Rep. 2016 07 08; 6:29523. Price DL, Rockenstein E, Mante M, Adame A, Overk C, Spencer B, Duong-Polk KX, Bonhaus D, Lindsey J, Masliah E. PMID: 27389831; PMCID: PMC4937425.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    24. Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity. J Neuroinflammation. 2016 05 24; 13(1):120. Fields JA, Overk C, Adame A, Florio J, Mante M, Pineda A, Desplats P, Rockenstein E, Achim C, Masliah E. PMID: 27220536; PMCID: PMC4879748.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    25. Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability. Alzheimers Dement. 2016 06; 12(6):633-44. de Wilde MC, Overk CR, Sijben JW, Masliah E. PMID: 26776762; PMCID: PMC5058345.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCells
    26. A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies. PLoS One. 2015; 10(3):e0121570. Rockenstein E, Overk CR, Ubhi K, Mante M, Patrick C, Adame A, Bisquert A, Trejo-Morales M, Spencer B, Masliah E. PMID: 25803611; PMCID: PMC4372415.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    27. Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions. ACS Chem Neurosci. 2015 Mar 18; 6(3):403-16. Tsigelny IF, Sharikov Y, Kouznetsova VL, Greenberg JP, Wrasidlo W, Overk C, Gonzalez T, Trejo M, Spencer B, Kosberg K, Masliah E. PMID: 25561023; PMCID: PMC4944825.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    28. Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders. Br J Pharmacol. 2014 Dec; 171(24):5757-73. Wrasidlo W, Crews LA, Tsigelny IF, Stocking E, Kouznetsova VL, Price D, Paulino A, Gonzales T, Overk CR, Patrick C, Rockenstein E, Masliah E. PMID: 25117211; PMCID: PMC4290715.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    29. Toward a unified therapeutics approach targeting putative amyloid-β oligomer receptors. Proc Natl Acad Sci U S A. 2014 Sep 23; 111(38):13680-1. Overk CR, Masliah E. PMID: 25205809; PMCID: PMC4183328.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    30. Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies. Mol Neurodegener. 2014 May 19; 9:18. Overk CR, Cartier A, Shaked G, Rockenstein E, Ubhi K, Spencer B, Price DL, Patrick C, Desplats P, Masliah E. PMID: 24885390; PMCID: PMC4041038.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    31. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain. 2014 May; 137(Pt 5):1496-513. Rockenstein E, Nuber S, Overk CR, Ubhi K, Mante M, Patrick C, Adame A, Trejo-Morales M, Gerez J, Picotti P, Jensen PH, Campioni S, Riek R, Winkler J, Gage FH, Winner B, Masliah E. PMID: 24662516; PMCID: PMC3999721.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansAnimalsCells
    32. Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD. Acta Neuropathol. 2014 Apr; 127(4):477-94. Nuber S, Tadros D, Fields J, Overk CR, Ettle B, Kosberg K, Mante M, Rockenstein E, Trejo M, Masliah E. PMID: 24509835; PMCID: PMC4324760.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    33. Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease. Biochem Pharmacol. 2014 Apr 15; 88(4):508-16. Overk CR, Masliah E. PMID: 24462903; PMCID: PMC3973539.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansCells
    34. Structural diversity of Alzheimer's disease amyloid-β dimers and their role in oligomerization and fibril formation. J Alzheimers Dis. 2014; 39(3):583-600. Tsigelny IF, Sharikov Y, Kouznetsova VL, Greenberg JP, Wrasidlo W, Gonzalez T, Desplats P, Michael SE, Trejo-Morales M, Overk CR, Masliah E. PMID: 24240640; PMCID: PMC4449729.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    35. Sex steroid levels and AD-like pathology in 3xTgAD mice. J Neuroendocrinol. 2013 Feb; 25(2):131-144. Overk CR, Perez SE, Ma C, Taves MD, Soma KK, Mufson EJ. PMID: 22889357; PMCID: PMC4065422.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    36. The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci. 2013 01; 14(1):38-48. Lashuel HA, Overk CR, Oueslati A, Masliah E. PMID: 23254192; PMCID: PMC4295774.
      View in: PubMed   Mentions: 677     Fields:    Translation:HumansAnimalsCells
    37. Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice. Neurobiol Dis. 2012 Jan; 45(1):479-87. Overk CR, Lu PY, Wang YT, Choi J, Shaw JW, Thatcher GR, Mufson EJ. PMID: 21945538; PMCID: PMC3225601.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    38. Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice. J Alzheimers Dis. 2011; 25(3):491-504. Kelley CM, Perez SE, Overk CR, Wynick D, Mufson EJ. PMID: 21471639; PMCID: PMC3307130.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    39. A novel approach for long-term oral drug administration in animal research. J Neurosci Methods. 2011 Feb 15; 195(2):194-9. Overk CR, Borgia JA, Mufson EJ. PMID: 21163304; PMCID: PMC3026878.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    40. Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease. J Chem Neuroanat. 2010 Sep; 40(1):63-70. Overk CR, Felder CC, Tu Y, Schober DA, Bales KR, Wuu J, Mufson EJ. PMID: 20347961; PMCID: PMC2864794.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    41. Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease. Neurobiol Dis. 2009 Sep; 35(3):415-25. Overk CR, Kelley CM, Mufson EJ. PMID: 19524671; PMCID: PMC3085918.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    42. Structural modulation of oxidative metabolism in design of improved benzothiophene selective estrogen receptor modulators. Drug Metab Dispos. 2009 Jan; 37(1):161-9. Qin Z, Kastrati I, Ashgodom RT, Lantvit DD, Overk CR, Choi Y, van Breemen RB, Bolton JL, Thatcher GR. PMID: 18936111; PMCID: PMC2683656.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    43. In vivo estrogenic comparisons of Trifolium pratense (red clover) Humulus lupulus (hops), and the pure compounds isoxanthohumol and 8-prenylnaringenin. Chem Biol Interact. 2008 Oct 22; 176(1):30-9. Overk CR, Guo J, Chadwick LR, Lantvit DD, Minassi A, Appendino G, Chen SN, Lankin DC, Farnsworth NR, Pauli GF, van Breemen RB, Bolton JL. PMID: 18619951; PMCID: PMC2574795.
      View in: PubMed   Mentions: 33     Fields:    Translation:AnimalsCells
    44. High-content screening and mechanism-based evaluation of estrogenic botanical extracts. Comb Chem High Throughput Screen. 2008 May; 11(4):283-93. Overk CR, Yao P, Chen S, Deng S, Imai A, Main M, Schinkovitz A, Farnsworth NR, Pauli GF, Bolton JL. PMID: 18473738; PMCID: PMC3219440.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    45. Estrogenic activity of the equine estrogen metabolite, 4-methoxyequilenin. Adv Exp Med Biol. 2008; 617:601-7. Chang M, Overk CR, Kastrati I, Peng KW, Yao P, Qin ZH, Petukhov P, Bolton JL, Thatcher GR. PMID: 18497087.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    46. Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene. ChemMedChem. 2007 Oct; 2(10):1520-6. Overk CR, Peng KW, Asghodom RT, Kastrati I, Lantvit DD, Qin Z, Frasor J, Bolton JL, Thatcher GR. PMID: 17654759.
      View in: PubMed   Mentions: 18     Fields:    Translation:Animals
    47. Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms. Mol Cancer Ther. 2007 Sep; 6(9):2418-28. Yu B, Dietz BM, Dunlap T, Kastrati I, Lantvit DD, Overk CR, Yao P, Qin Z, Bolton JL, Thatcher GR. PMID: 17876041.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    48. Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells. Endocrinology. 2007 Oct; 148(10):4793-802. Chang M, Peng KW, Kastrati I, Overk CR, Qin ZH, Yao P, Bolton JL, Thatcher GR. PMID: 17584965.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    49. The chemical and biologic profile of a red clover (Trifolium pratense L.) phase II clinical extract. J Altern Complement Med. 2006 Mar; 12(2):133-9. Booth NL, Overk CR, Yao P, Burdette JE, Nikolic D, Chen SN, Bolton JL, van Breemen RB, Pauli GF, Farnsworth NR. PMID: 16566672; PMCID: PMC1780253.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    50. Seasonal variation of red clover (Trifolium pratense L., Fabaceae) isoflavones and estrogenic activity. J Agric Food Chem. 2006 Feb 22; 54(4):1277-82. Booth NL, Overk CR, Yao P, Totura S, Deng Y, Hedayat AS, Bolton JL, Pauli GF, Farnsworth NR. PMID: 16478248; PMCID: PMC1903374.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    51. Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J Agric Food Chem. 2005 Aug 10; 53(16):6246-53. Overk CR, Yao P, Chadwick LR, Nikolic D, Sun Y, Cuendet MA, Deng Y, Hedayat AS, Pauli GF, Farnsworth NR, van Breemen RB, Bolton JL. PMID: 16076101; PMCID: PMC1815392.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    52. Estrogens and congeners from spent hops (Humulus lupulus). J Nat Prod. 2004 Dec; 67(12):2024-32. Chadwick LR, Nikolic D, Burdette JE, Overk CR, Bolton JL, van Breemen RB, Fröhlich R, Fong HH, Farnsworth NR, Pauli GF. PMID: 15620245; PMCID: PMC7418824.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    53. Purification, structure determination, and antimicrobial activity of neutramycins B-G. J Nat Prod. 2003 Sep; 66(9):1149-53. Graziani EI, Overk CR, Carter GT. PMID: 14510587.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    54. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin. Chem Res Toxicol. 2003 Jun; 16(6):741-9. Liu X, Zhang F, Liu H, Burdette JE, Li Y, Overk CR, Pisha E, Yao J, van Breemen RB, Swanson SM, Bolton JL. PMID: 12807357.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Cassia's Networks
    Concepts (316)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-2-gbbe5f151 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California